Characterization of human respiratory syncytial virus (RSV) isolated from HIV‐exposed‐uninfected and HIV‐unexposed infants in South Africa during 2015‐2017-Reference-Cited by-同舟云学术

Characterization of human respiratory syncytial virus (RSV) isolated from HIV‐exposed‐uninfected and HIV‐unexposed infants in South Africa during 2015‐2017

Published:2020-03-03 Issue:4 Volume:14 Page:403-411
ISSN:1750-2640
Container-title:Influenza and Other Respiratory Viruses
language:en
Short-container-title:Influenza Other Respi Viruses

Author:

Liu Hui¹^ORCID,Lu Bin¹,Tabor David E.¹,Tovchigrechko Andrey²,Wilkins Deidre²,Jin Hong¹,Madhi Shabir A.³⁴,Soofie Nasiha³⁴,Esser Mark T.²,Nunes Marta C.³⁴

Affiliation:

1. AstraZeneca South San Francisco CA USA

2. AstraZeneca Gaithersburg MD USA

3. Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases Faculty of Health Sciences University of the Witwatersrand Johannesburg South Africa

4. Medical Research Council: Respiratory and Meningeal Pathogens Research Unit Faculty of Health Sciences University of the Witwatersrand Johannesburg South Africa

Funder

AstraZeneca

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/irv.12727

Reference37 articles.

1. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study

2. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

3. Potent High-Affinity Antibodies for Treatment and Prophylaxis of Respiratory Syncytial Virus Derived from B Cells of Infected Patients